Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 862-873

  Moreno, Ignacio ^a   Caballero, Ricardo ^a   González, Teresa ^a   Arias, Cristina ^a   Valenzuela, Carmen ^a   Iriepa, Isabel ^b   Gálvez, Enrique ^b   Tamargo, Juan ^a   Delpón, Eva ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRBESARTAN; POTASSIUM CHANNEL; PROTEIN; PROTEIN HERG; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HEART REPOLARIZATION; MEMBRANE CURRENT; MEMBRANE POTENTIAL; MOLECULAR MECHANICS; MOLECULAR MODEL; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; BIPHENYL COMPOUNDS; CATION TRANSPORT PROTEINS; CHO CELLS; CLONING, MOLECULAR; COMPUTER SIMULATION; CRICETINAE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHER-A-GO-GO POTASSIUM CHANNELS; HEART; HUMANS; KV1.5 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; MODELS, MOLECULAR; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TETRAZOLES; TRANS-ACTIVATORS;

EID: 0037308146     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.042325     Document Type: Article

References (28)

1. Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175-187.
2. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, and Romey G (1996) KvLQT1 and IsK (minK) proteins associate to form the cardiac potassium current. Nature (Lond) 384:78-80.
3. Caballero R, Delpón E, Valenzuela C, Longobardo M, González T, and Tamargo J (2001a) Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization. Mol Pharmacol 59:825-836.
4. + currents. Circulation 101:1199-1205.
5. Caballero R, Moreno I, Gonzalez T, Valenzuela C, Tamargo J, and Delpón E (2002) Putative binding site for benzocaine on a human cardiac cloned channel (Kv1.5). Cardiovasc Res 56:104-117.
6. Caballero R, Pourrier M, Schram G, Delpón E, Tamargo J, and Nattel S (2001b) A critical role for S6 valines in the pharmacological properties of transient outward current (Ito) carried by Kv4.2 subunits. Circulation 104:II217.
7. a determination of angiotensin II receptor antagonists (ARA II) by spectrofluorometry. J Pharm Biomed Anal. 26:477-486.
8. + channel and its structural implications. Nature (Lond) 403:321-325.
9. + conduction and selectivity. Science (Wash DC) 280:69-77.
10. Franqueza L, Longobardo M, Vicente J, Delpón E, Tamkun M, Tamargo J, Snyders D, and Valenzuela C (1997) Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ Res 81:1053-1064.
11. Lim P, Nys M, Naas A, Struthers A, Osbakken M, and MacDonald T (1999) Irbesartan reduces QT dispersion in hypertensive individuals. Hypertension 33:713-718.
12. Madrid A, Bueno M, Rebollo J, Marin I, Pena G, Bernal E, Rodriguez A, Cano L, Cano J, Cabeza P, and Moro C (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 106:331-336.
13. Markham A, Spencer C, and Jarvis B (2000) Irbesartan: an update review of its use in cardiovascular disorders. Drugs 59:23-33.
14. Mitcheson J, Chen J, Lin M, Culberson C, and Sanguinetti M (2000a) A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97:12329-12333.
15. Morreale A, Maseras F, Iriepa I, and Gálvez E (2002) Ligand-receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model. J Mol Graph Model 21:111-118.
16. + channel diversity in the mammalian myocardium. J Physiol. (Lond) 525:285-298.
17. Rich T, Yeola S, Tamkun M, and Snyders D (2002) Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate. Am J Physiol 282:C161-C171.
18. Rosati B, Pan Z, Lypen S, Wang H, Cohen I, Dixon J, and McKinnon D (2001) Regulation of KChIP2 potassium channel. J Physiol (Lond) 533:119-125.
19. + channel block. J Biol Chem 277:23587-23595.
20. Ks potassium channel. Nature (Lond) 384:80-83.
21. Kr potassium channel. Cell 81:299-307.
22. Kr: the HERG channel. J Mol Cell Cardiol 33:835-849.
23. + current similar to Kv1.5 cloned channels currents. Circ Res 73:1061-1076.
24. + current in rabbit and human atrial myocytes. Circ Res 84:551-561.
25. Waud D (1968) Pharmacological receptors. Pharmacol Rev 20:49-88.
26. Weerapura M, Nattel S, Chartier D, Caballero R, and Hebert T (2002) A comparison of currents carried by HERG, with and without coexpression of MiRP1 and the native rapid delayed rectifier current. Is MiRP1 the missing link? J Physiol (Lond) 540:15-27.
27. + channel. Role of S6 in antiarrhythmic drug binding. Circ Res 78:1105-1114.
28. Zhang H, Zhu B, Yao J, and Tseng G (1998) Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity. J Pharmacol Exp Ther 287:332-343.